Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K+ channels

被引:58
作者
Dong, D [1 ]
Duan, YJ [1 ]
Guo, JQ [1 ]
Roach, DE [1 ]
Swirp, SL [1 ]
Wang, L [1 ]
Lees-Miller, JP [1 ]
Sheldon, RS [1 ]
Molkentin, JD [1 ]
Duff, HJ [1 ]
机构
[1] Univ Calgary, Dept Med, Cardiovasc Res Grp, Calgary, AB T2N 4N1, Canada
关键词
K-channel; repolarization; sudden death;
D O I
10.1016/S0008-6363(02)00661-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Overexpression of calcineurin in transgenic (TG) mice results in cardiac hypertrophy and unexpected deaths. Methods and results: None of the TG survived beyond 24 weeks (n=38) whereas all of the wildtype (WT, n=47) survived. Prolongation of repolarization preceded the development of sustained pleomorphic ventricular tachycardia and high degree atrioventricular block, which occurred during spontaneous sudden deaths. Since depolarization-activated K+ channels contribute dominantly to repolarization in mice, we hypothesized that the TG would decrease these K+ currents and that the in vivo administration of cyclosporin A (CsA), a calcineurin inhibitor, would reduce this effect. CsA reversed cardiac hypertrophy: capacitance measurements of WT left ventricular myocytes (127+/-7 pF; n=45) and CsA-treated TG (129+/-14 pF; n=17) were significantly lower than in placebo-treated TG (220+/-11 pF; n=41; P<0.001 by ANOVA). Independent of whether the data fit a bi- or a tri-exponential model, the density of I-tof was significantly reduced in TG versus WT and CsA reversed this effect. While I-tos and I-Kslow were also reduced in TG, CsA does not reverse this change because long-term in vivo CsA treatment of WT also reduces I-tos and I-Kslow To assess whether the decreased 'repolarization reserve' contributed to arrhythmogenesis, the residual I-Kr was blocked by dofetilide precipitating pleomorphic ventricular tachycardias. Conclusion: Since the downregulation of I-tof was observed with overexpression of calcineurin and was also reversed by the calcineurin inhibitor CsA, we conclude that downregulation of I-tof is a consequence of calcineurin overexpression. (C) 2003 European Society of Cardiology. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:320 / 332
页数:13
相关论文
共 45 条
  • [21] Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition
    Lim, HW
    De Windt, LJ
    Mante, J
    Kimball, TR
    Witt, SA
    Sussman, MA
    Molkentin, JD
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (04) : 697 - 709
  • [22] LUO Z, 1998, CARDIOVASC RES, V37, P312
  • [23] Calcineurin inhibitors and cardiac hypertrophy
    Luo, ZY
    Shyu, KG
    Gualberto, A
    Walsh, K
    [J]. NATURE MEDICINE, 1998, 4 (10) : 1092 - 1093
  • [24] Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure
    Meguro, T
    Hong, C
    Asai, K
    Takagi, G
    McKinsey, TA
    Olson, EN
    Vatner, SF
    [J]. CIRCULATION RESEARCH, 1999, 84 (06) : 735 - 740
  • [25] Measurement of heart rate and Q-T interval in the conscious mouse
    Mitchell, GF
    Jeron, A
    Koren, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (03): : H747 - H751
  • [26] A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
    Molkentin, JD
    Lu, JR
    Antos, CL
    Markham, B
    Richardson, J
    Robbins, J
    Grant, SR
    Olson, EN
    [J]. CELL, 1998, 93 (02) : 215 - 228
  • [27] Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium
    Nerbonne, JM
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2000, 525 (02): : 285 - 298
  • [28] Oie E, 2000, AM J PHYSIOL-HEART C, V278, pH2115
  • [29] VOLTAGE-CLAMP AND SPACE-CLAMP ERRORS ASSOCIATED WITH THE MEASUREMENT OF ELECTROTONICALLY REMOTE SYNAPTIC EVENTS
    SPRUSTON, N
    JAFFE, DB
    WILLIAMS, SH
    JOHNSTON, D
    [J]. JOURNAL OF NEUROPHYSIOLOGY, 1993, 70 (02) : 781 - 802
  • [30] Hypertrophic defect unmasked by calcineurin expression in asymptomatic tropomodulin overexpressing transgenic mice
    Sussman, MA
    Welch, S
    Walker, A
    Klevitsky, R
    Hewett, TE
    Witt, SA
    Kimball, TR
    Price, R
    Lim, HW
    Molkentin, JD
    [J]. CARDIOVASCULAR RESEARCH, 2000, 46 (01) : 90 - 101